A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Recruiting now
Conditions studied: Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL)
In brief
The TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies. It will collect rich molecular (multi-omic) and clinical data from patient cohorts through serial blood draws and the acquisition of leftover tissue and/or bone marrow aspirates during their routine therapy and disease monitoring. The primary goal is to understand the association between biomarkers and real-world clinical outcomes in these patient populations.
Key facts
- Study ID
- NCT07154823
- Run by
- Tempus AI
- People needed
- 550
- Starts
- 2026-01-27
- Expected to finish
- 2035-11-01
- Last updated by the study team
- 2026-07-21
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Iowa Hospital and Clinics — Iowa City, Iowa, United States (enrolling)
- The Center for Cancer and Blood Disorders — Bethesda, Maryland, United States (enrolling)
- Washington University in St. Louis — St Louis, Missouri, United States (enrolling)
- Cancer Care Specialists of Reno — Reno, Nevada, United States (enrolling)
- University of Cincinnati — Cincinnati, Ohio, United States (enrolling)
- OhioHealth Research Institute — Columbus, Ohio, United States (enrolling)
- Taylor Cancer Research Center — Maumee, Ohio, United States (enrolling)
- Cancer Care Associates of York — York, Pennsylvania, United States (enrolling)
- Avera Cancer Institue — Sioux Falls, South Dakota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.